2'-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood. [PDF]
Kaur H +9 more
europepmc +1 more source
<i>Bifidobacterium longum</i> Subspecies <i>infantis</i> M63 Enhances the Colitis-Alleviating Effect of 2'-Fucosyllactose by Restoring Intestinal Barrier Function and Microbial Metabolism. [PDF]
Zhang H, Li X, Tan M, Bao Y, Jiang S.
europepmc +1 more source
Precision synbiotic intervention with 2'-fucosyllactose and infant-derived <i>Bifidobacterium</i> modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial. [PDF]
Chen K +15 more
europepmc +1 more source
Effect of a Synbiotic Combination of 2'-Fucosyllactose and <i>Lactiplantibacillus plantarum Hi188</i> on Skeletal Growth and Gut Microbial Metabolism in Growing Mice. [PDF]
Kuang J +9 more
europepmc +1 more source
Hypoallergenicity of a hydrolyzed rice protein-based formula containing 2-fucosyllactose and lacto-N-neotetraose in children with cow's milk allergy: protocol for a randomized controlled study. The RIGHT-HY study. [PDF]
Zemrani B +11 more
europepmc +1 more source
2'-Fucosyllactose mitigates cognitive deficits in Alzheimer models: targeting amyloid pathology, oxidative stress, and synaptic plasticity. [PDF]
Munni YA +8 more
europepmc +1 more source
2'-Fucosyllactose and its metabolites propionate/butyrate suppress inflammation through a shared TLR4/p38 MAPK-dependent pathway <i>in vitro</i> and <i>in vivo</i>. [PDF]
Na K +9 more
europepmc +1 more source
Growth and safety of infants with cow's milk allergy receiving a new hydrolyzed rice protein-based formula containing 2-fucosyllactose and lacto-N-neotetraose: protocol for a randomized clinical trial. The RIGHT-GO study. [PDF]
Zemrani B +6 more
europepmc +1 more source
Supplementation of 2'-Fucosyllactose in Formula-Fed Infants Has Potential Benefits to Reduce the Risks of Infantile Colic and Atopic Dermatitis in Infancy. [PDF]
Yang YJ, Lo HY, Huang SC.
europepmc +1 more source
2'-Fucosyllactose supplementation results in a transient improvement in gut microbial resilience after vancomycin use in adults with overweight or obesity: a randomized, double-blind, placebo-controlled intervention. [PDF]
Vliex LMM +9 more
europepmc +1 more source

